Vascularized brain organoids enable reconstruction of the human blood-brain barrier and neurovascular disease modelling
This study establishes a scalable platform of vascularized human brain organoids that recapitulates the neurovascular unit and blood-brain barrier, enabling the investigation of human-specific BBB biology, development, and neurovascular diseases through in vitro and in vivo models.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
The human brain is a fortress, protected by a highly selective gatekeeper known as the blood-brain barrier. This barrier is a thin, specialized wall of cells that lines the tiny blood vessels inside the brain, allowing essential nutrients to pass through while keeping out harmful substances and infections. For decades, scientists have struggled to study how this barrier forms, how it works, and what happens when it breaks down in diseases. Traditional methods, such as growing flat layers of cells in a dish, fail to capture the complex, three-dimensional structure of the brain. Meanwhile, early attempts to grow miniature brains from stem cells, called organoids, often resulted in clumps of tissue that lacked blood vessels. Without a blood supply, these tiny brains could not grow large enough to be useful, and their centers often died from a lack of oxygen.
To solve this, researchers have been searching for a way to build a living model that includes both brain tissue and a working network of blood vessels. This is crucial because the barrier is not just a static wall; it is a dynamic interface where blood vessels talk to brain cells to maintain health. When this communication fails, it can lead to devastating conditions ranging from infections that cross into the brain to genetic disorders that destroy brain tissue. Until now, no single model has successfully combined a developing human brain with a functional, human blood vessel system that mimics the real thing.
A team of scientists has now created a new, scalable platform that bridges this gap. They developed a method to grow vascularized human brain organoids, which are miniature, three-dimensional models of the human brain that contain their own integrated network of blood vessels. The process begins with human stem cells, which are guided to form small spheres of brain tissue. At a specific early stage, the researchers embed these developing spheres in a gel containing human blood vessel cells and supporting cells called pericytes. This simple step triggers the formation of a stable, branching network of vessels that grows directly into the brain tissue. Unlike previous attempts that required complex genetic engineering, this approach relies on the natural ability of these cells to organize themselves when placed together early in development.
The researchers tested several different types of blood vessel cells to see which would work best. They found that a specific type of cell, derived from the umbilical cord and modified to survive longer in culture, was the most effective at creating a robust network. When these cells were combined with pericytes, the resulting organoids developed a dense web of vessels that penetrated deep into the brain tissue. These vessels were not just empty tubes; they developed the tight seals and specialized transport proteins that characterize the real blood-brain barrier. The team observed that the presence of these vessels improved the overall health of the organoid, reducing the death of cells in the center and allowing the brain tissue to mature further than it could without a blood supply.
To confirm that these artificial vessels were truly functional, the scientists took the organoids and implanted them under the skin of mice with weakened immune systems. Within three weeks, the human blood vessels inside the organoids connected directly to the mouse's own circulatory system. Blood from the mouse flowed through the human vessels, and the vessels themselves became more mature, acquiring additional features of the human blood-brain barrier that were missing in the dish. This proved that the model could not only survive but also integrate with a living host, responding to the flow of blood in a way that mimics human physiology.
Using this new model, the team investigated how the blood-brain barrier behaves during disease. In one experiment, they infected the mice with Neisseria meningitidis, a bacterium that causes meningitis in humans but cannot infect mice naturally. The bacteria selectively attached to the human blood vessels inside the organoids, ignoring the mouse vessels nearby. The researchers watched as the bacteria caused the vessel walls to remodel, triggered the formation of blood clots, and eventually breached the barrier to invade the brain tissue. This provided a rare, real-time view of how a human-specific infection attacks the brain, a process that is impossible to study in standard animal models.
In a second application, the team used the platform to study Alexander disease, a rare genetic disorder caused by mutations in a protein called GFAP, which is essential for brain support cells. They grew organoids using stem cells from patients with this disease and compared them to healthy controls. They found that the genetic mutations caused the support cells to clump together abnormally and move further away from the blood vessels. This disruption in the spatial arrangement of cells led to a leaky blood-brain barrier, allowing substances to escape from the vessels into the brain tissue. This suggests that the root of the disease involves a breakdown in the physical relationship between support cells and blood vessels, leading to barrier failure.
The creation of these vascularized brain organoids marks a significant step forward in understanding human brain biology. By providing a model that includes a working blood supply and a functional barrier, the researchers have opened the door to studying diseases and testing treatments in a system that closely resembles the human brain. The ability to observe how blood vessels interact with brain cells in a living, perfused environment offers a powerful new tool for uncovering the mechanisms of neurological disorders and for developing therapies that can protect or repair the blood-brain barrier.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.